+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zinacef"

Cephalosporin Global Market Report 2024 - Product Thumbnail Image

Cephalosporin Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Zinacef is a brand of cefuroxime, an antibiotic used to treat infections of the central nervous system (CNS). It is used to treat bacterial meningitis, brain abscesses, and other CNS infections caused by susceptible bacteria. It is also used to treat bacterial infections of the skin, urinary tract, and respiratory tract. Zinacef is available in both oral and injectable forms. The injectable form is used for more serious infections, while the oral form is used for milder infections. Zinacef is a part of the larger market of CNS drugs, which includes antibiotics, anticonvulsants, antipsychotics, and other medications used to treat neurological disorders. These drugs are used to treat a wide range of conditions, including epilepsy, Alzheimer's disease, Parkinson's disease, and schizophrenia. Companies in the Zinacef market include GlaxoSmithKline, Pfizer, Merck, and Sanofi. Show Less Read more